Scientists shut down cancer DNA repair to overcome drug resistance
Researchers have discovered that UNI418 can inhibit the DNA repair mechanism in cancer cells, enhancing the effectiveness of treatments. This strategy, especially when paired with a PARP inhibitor, shows promise in reversing drug resistance in challenging cancer cases.




